ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 377 filers reported holding ENCOMPASS HEALTH CORP in Q1 2020. The put-call ratio across all filers is 0.63 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $217,000 | -30.4% | 3,335 | -19.7% | 0.00% | 0.0% |
Q3 2021 | $312,000 | -10.3% | 4,154 | -6.8% | 0.00% | 0.0% |
Q2 2021 | $348,000 | -4.9% | 4,457 | -0.2% | 0.00% | -20.0% |
Q1 2021 | $366,000 | -4.2% | 4,465 | -3.3% | 0.01% | -16.7% |
Q4 2020 | $382,000 | +12.0% | 4,619 | -12.1% | 0.01% | 0.0% |
Q3 2020 | $341,000 | -17.8% | 5,254 | -21.5% | 0.01% | -25.0% |
Q2 2020 | $415,000 | -29.7% | 6,697 | -27.3% | 0.01% | -42.9% |
Q1 2020 | $590,000 | -41.2% | 9,212 | -36.5% | 0.01% | -22.2% |
Q4 2019 | $1,004,000 | -4.8% | 14,500 | -13.1% | 0.02% | -14.3% |
Q3 2019 | $1,055,000 | -5.3% | 16,679 | -5.2% | 0.02% | -43.2% |
Q2 2019 | $1,114,000 | +1.0% | 17,586 | -6.9% | 0.04% | -15.9% |
Q1 2019 | $1,103,000 | -6.6% | 18,886 | -1.3% | 0.04% | -12.0% |
Q4 2018 | $1,181,000 | -28.3% | 19,136 | -9.5% | 0.05% | -13.8% |
Q3 2018 | $1,648,000 | +13.2% | 21,148 | -1.7% | 0.06% | +3.6% |
Q2 2018 | $1,456,000 | +15.7% | 21,507 | -2.3% | 0.06% | +16.7% |
Q1 2018 | $1,258,000 | – | 22,010 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Iron Triangle Partners LP | 697,659 | $45,334,000 | 10.13% |
JANA PARTNERS LLC | 1,741,513 | $113,164,000 | 10.12% |
Endurant Capital Management LP | 276,105 | $17,941,000 | 5.31% |
REINHART PARTNERS, LLC. | 726,140 | $47,184,000 | 3.55% |
Prosight Management, LP | 107,921 | $7,013,000 | 3.34% |
Advantage Alpha Capital Partners LP | 160,234 | $10,412,000 | 2.41% |
RK Capital | 115,800 | $7,525,000 | 2.13% |
Copeland Capital Management, LLC | 700,015 | $45,487,000 | 2.02% |
Sivik Global Healthcare LLC | 65,000 | $4,224,000 | 1.82% |
Walthausen & Co., LLC | 120,016 | $7,799,000 | 1.62% |